Metabolic Disturbances Independent of Body Mass in Patients with Schizophrenia Taking Atypical Antipsychotics
Shi Hyun Kang, Jong Il Lee
Psychiatry Investig. 2015;12(2):242-248.   Published online 2015 Mar 18     DOI: https://doi.org/10.4306/pi.2015.12.2.242
Metabolic adverse effects of off-label use of second-generation antipsychotics in the adult population: a systematic review and meta-analysis
Nicolette Stogios, Emily Smith, Sylvie Bowden, Veronica Tran, Roshanak Asgariroozbehani, William Brett McIntyre, Gary Remington, Dan Siskind, Sri Mahavir Agarwal, Margaret K. Hahn
Neuropsychopharmacology.2022; 47(3): 664.     CrossRef
Long-term metabolic and inflammatory effects of second-generation antipsychotics: A study in mentally disordered offenders
Emilia Vassilopoulou, Dimitris Efthymiou, Evangelia Papatriantafyllou, Maria Markopoulou, Efthymia-Maria Sakellariou, Alina-Codruța Popescu
Public Health and Toxicology.2022;[Epub]     CrossRef
Natural cause mortality of mental health consumers: A 10‐year retrospective cohort study
Joanne Suggett, Kim Foster, Vinay Lakra, Michael Steele, Trentham Furness
International Journal of Mental Health Nursing.2021; 30(2): 390.     CrossRef
Secondary dyslipidemia: its treatments and association with atherosclerosis
Hidekatsu Yanai, Hiroshi Yoshida
Global Health & Medicine.2021; 3(1): 15.     CrossRef
Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences
Marco Carli, Shivakumar Kolachalam, Biancamaria Longoni, Anna Pintaudi, Marco Baldini, Stefano Aringhieri, Irene Fasciani, Paolo Annibale, Roberto Maggio, Marco Scarselli
Pharmaceuticals.2021; 14(3): 238.     CrossRef
Long Term Metabolic and Inflammatory Effects of Second-Generation Antipsychotics: A Study in Mentally Disordered Offenders
Emilia Vassilopoulou, Dimitris Efthymiou, Evangelia Papatriantafyllou, Maria Markopoulou, Efthymia-Maria Sakellariou, Alina Codruta Popescu
Journal of Personalized Medicine.2021; 11(11): 1189.     CrossRef
Sex differences in the association of body mass index with symptoms and cognitive deficits in Chinese patients with chronic schizophrenia
Chang Wei Wei, Ying Qi Chen, Mi Ma, Mei Hong Xiu, Xiang Yang Zhang
Translational Psychiatry.2020;[Epub]     CrossRef
A higher body mass index in Chinese inpatients with chronic schizophrenia is associated with elevated plasma orexin-A levels and fewer negative symptoms
Zhiwei Liu, Yulong Zhang, Tongtong Zhao, Juan Wang, Lei Xia, Yi Zhong, Yating Yang, Xiaoshuai Ning, Yelei Zhang, Zhenhua Ren, Huanzhong Liu
Nordic Journal of Psychiatry.2020; 74(7): 525.     CrossRef
Homocysteine level, body mass index and clinical correlates in Chinese Han patients with schizophrenia
Yuanyuan Huang, Kai Wu, Hehua Li, Jing Zhou, Dongsheng Xiong, Xia Huang, Jiahui Li, Ya Liu, Zhilin Pan, David T. Mitchell, Fengchun Wu, Xiang Yang Zhang
Scientific Reports.2020;[Epub]     CrossRef
Orexin-A Levels in Relation to the Risk of Metabolic Syndrome in Patients with Schizophrenia Taking Antipsychotics
Po-Yu Chen, Chun-Hsin Chen, Chin-Kuo Chang, Chung-Feng Kao, Mong-Liang Lu, Shih-Ku Lin, Ming-Chyi Huang, Ling-Ling Hwang, Valeria Mondelli
International Journal of Neuropsychopharmacology.2019; 22(1): 28.     CrossRef
Antipsychotics Promote Metabolic Disorders Disrupting Cellular Lipid Metabolism and Trafficking
Chiara Vantaggiato, Elena Panzeri, Andrea Citterio, Genny Orso, Marco Pozzi
Trends in Endocrinology & Metabolism.2019; 30(3): 189.     CrossRef
Assessing the risk of type 2 diabetes mellitus among children and adolescents with psychiatric disorders treated with atypical antipsychotics: a population-based nested case–control study
Hankil Lee, Dong-Ho Song, Jin-Won Kwon, Euna Han, Min-Jung Chang, Hye-Young Kang
European Child & Adolescent Psychiatry.2018; 27(10): 1321.     CrossRef
Increase in serum HDL level is associated with less negative symptoms after one year of antipsychotic treatment in first-episode psychosis
Priyanthi B. Gjerde, Ingrid Dieset, Carmen Simonsen, Eva Z. Hoseth, Trude Iversen, Trine V. Lagerberg, Siv Hege Lyngstad, Ragni H. Mørch, Silje Skrede, Ole A. Andreassen, Ingrid Melle, Vidar M. Steen
Schizophrenia Research.2018; 197: 253.     CrossRef
T4 and waist:hip ratio as biomarkers of antipsychotic-induced weight gain in Han Chinese inpatients with schizophrenia
Shen Li, Ying Gao, Hao Lv, Miaomiao Zhang, Lili Wang, Rui Jiang, Chengai Xu, Xueshi Wang, Ming Gao, Yukun He, Jie Li, Wei-Dong Li
Psychoneuroendocrinology.2018; 88: 54.     CrossRef
High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey
Shin Ono, Takuro Sugai, Yutaro Suzuki, Manabu Yamazaki, Kazutaka Shimoda, Takao Mori, Yuji Ozeki, Hiroshi Matsuda, Norio Sugawara, Norio Yasui-Furukori, Kurefu Okamoto, Toyoaki Sagae, Toshiyuki Someya
BMC Psychiatry.2018;[Epub]     CrossRef
Prevalence of Prolonged QTC Interval in Patients Taking Psychopharmacs
Zoran Jovanovic, Vesela Radonjic, Ratomir Jelic, Narcisa Petrovic-Subic, Ivan Soldatovic, Vera Terzic, Sladjan Stojilkovic, Dusan Djuric
Serbian Journal of Experimental and Clinical Research.2018; 19(2): 159.     CrossRef
Disturbances of glucose metabolism associated with the use of psychotropic drugs: A post-mortem evaluation
Cristian Palmiere, Marc Augsburger, Vincent Varlet
Forensic Science International.2017; 274: 33.     CrossRef
The prevalence, risk factors and clinical correlates of obesity in Chinese patients with schizophrenia
Qiongzhen Li, Xiangdong Du, Yingyang Zhang, Guangzhong Yin, Guangya Zhang, Consuelo Walss-Bass, João Quevedo, Jair C. Soares, Haishen Xia, Xiaosi Li, Yingjun Zheng, Yuping Ning, Xiang Yang Zhang
Psychiatry Research.2017; 251: 131.     CrossRef
Intrinsic and Antipsychotic Drug-Induced Metabolic Dysfunction in Schizophrenia
Zachary Freyberg, Despoina Aslanoglou, Ripal Shah, Jacob S. Ballon
Frontiers in Neuroscience.2017;[Epub]     CrossRef
Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future Directions
Mahmoud Slim, Inmaculada Medina-Caliz, Andres Gonzalez-Jimenez, M. Rosario Cabello, Fermin Mayoral-Cleries, M. Isabel Lucena, Raul J. Andrade
Drug Safety.2016; 39(10): 925.     CrossRef
Sex Differences in Body Mass Index and Obesity in Chinese Patients With Chronic Schizophrenia
Qiongzhen Li, Dachuan Chen, Tiebang Liu, Consuelo Walss-Bass, Joao L. de Quevedo, Jair C. Soares, Jingping Zhao, Xiang Yang Zhang
Journal of Clinical Psychopharmacology.2016; 36(6): 643.     CrossRef
Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive Review
Benedicto Crespo-Facorro, Jose Maria Pelayo-Teran, Jacqueline Mayoral-van Son
Neurology and Therapy.2016; 5(2): 105.     CrossRef
Circadian Clocks as Modulators of Metabolic Comorbidity in Psychiatric Disorders
Rita Barandas, Dominic Landgraf, Michael J. McCarthy, David K. Welsh
Current Psychiatry Reports.2015;[Epub]     CrossRef
Early insulin resistance predicts weight gain and waist circumference increase in first-episode psychosis – A one year follow-up study
Jaakko Keinänen, Outi Mantere, Tuula Kieseppä, Teemu Mäntylä, Minna Torniainen, Maija Lindgren, Jouko Sundvall, Jaana Suvisaari
Schizophrenia Research.2015; 169(1-3): 458.     CrossRef